Furthermore, the correlation between NCAPG2 and selected immune features, such as immune cell infiltration, immune checkpoint genes, tumor mutational burden (TMB), microsatellite instability (MSI), and other oncological features, indicates that NCAPG2 could potentially be applied in the guidance of immunotherapy. Here, NCAPG2 is linked to neoplasm.